Identification
CAS Number
1062122-63-7
Name
Everolimus Impurity Everolimus-19-ene open ring(804-95)
Synonyms
(2S)-1-{(2R,3R,6S)-2-Hydroxy-6-{(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3 ,5,7,15,19-docosapentaen-1-yl}-3-methyltetrahydro-2H-pyran-2-ylacetyl}-2-piperidincarbonsäure [German] [ACD/IUPAC Name]
(2S)-1-{(2R,3R,6S)-2-Hydroxy-6-{(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3 ,5,7,15,19-docosapentaen-1-yl}-3-methyltetrahydro-2H-pyran-2-ylacetyl}-2-piperidinecarboxylic acid [ACD/IUPAC Name]
2-Piperidinecarboxylic acid, 1-[1,2-dioxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dim ethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]ethyl]-, (2S)- [ACD/Index Name]
Acide (2S)-1-{2-[(2R,3R,6S)-2-hydroxy-6-{(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyéthoxy)-3-méthoxycyclohexyl]-2,13-diméthoxy-3,9,11,15,17,21-hexaméthyl-12,18 -dioxo-3,5,7,15,19-docosapentaén-1-yl}-3-méthyltétrahydro-2H-pyran-2-yl]-2-oxoacétyl}-2-pipéridinecarboxylique [French] [ACD/IUPAC Name]
(2S)?-1-?[2-?oxo-?2-?[(2R,?3R,?6S)?-?tetrahydro-?2-?hydroxy-?6-?[(2S,?3E,?5E,?7E,?9S,?11R,?13R,?14R,?15E,?17R,?19E,?21R)?-?14-?hydroxy-?22-?[(1S,?3R,?4R)?-?4-?(2-?hydroxyethoxy)?-?3-?methoxycyclohexyl]?-?2,?13-?dimethoxy-?3,?9,?11,?15,?17,?21-?hexamethyl-?12,?18-?dioxo-?3,?5,?7,?15,?19-?docosapentaen-?1-?yl]?-?3-?methyl-?2H-?pyran-?2-?yl]?acetyl]?-?2-?Piperidinecarboxylic acid
1062122-63-7 [RN]
SMILES
C[C@@H]1CC[C@H](O[C@]1(C(=O)C(=O)N2CCCC[C@H]2C(=O)O)O)C[C@@H](/C(=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@@H]([C@@H](/C(=C/[C@@H](C)C(=O)/C=C/[C@H](C)C[C@@H]3CC[C@H]([C@@H](C3)OC)OCCO)/C)O)OC)/C)OC
StdInChI
InChI=1S/C53H83NO14/c1-33(16-12-11-13-17-35(3)45(64-8)32-41-22-20-39(7)53(63,68-41)50(59)51(60)54-25-15-14-18-42(54)52(61)62)28-37(5)47(57)49(66-10)48(58)38(6)30-36(4)43(56)23-19-34(2)29-40-21-24-44(67-27-26-55)46(31-40)65-9/h11-13,16-17,19,23,30,33-34,36-37,39-42,44-46,48-49,55,58,63H,14-15,18,20-22,24-29,31-32H2,1-10H3,(H,61,62)/b13-11+,16-12+,23-19+,35-17+,38-30+/t33-,34+,36-,37-,39-,40+,41+,42+,44-,45+,46-,48-,49+,53-/m1/s1
StdInChIKey
PRSJHEVLVQFMHJ-FRLQEACCSA-N
Molecular Formula
C53H83NO14
Molecular Weight
958.224
Properties
Appearance
White solid
Safety Data
WGK Germany
3
Specifications and Other Information of Our Everolimus Impurity Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
Identification Methods
HNMR, HPLC
Purity
≥95%
Shelf Life
2 years
Storage
Store at 2-8℃, sealed and away from light.
Known Application
Often used as an impurity for Everolimus.
General View of Documents
Links
This product is developed by our R&D company Caming Pharmaceutical Ltd (https://www.caming.com/).
Quick Inquiry
Fill out our inquiry form and one of our experts will be in touch with you shortly.